Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EP...(2500 4607 Deferred rent ...),Health
2,500 4,607
Deferred rent - 10
Deferred compensation plan liabilities 2,330 1,893
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.0001 par value per share,
20,000,000 shares authorized, none issued
and outstanding - -
Common stock, $0.0001 par value per share;
200,000,000 shares authorized, 54,374,929
and 53,916,298 shares issued and outstanding
at September 30, 2008 and December 31, 2007,
respectively 5 5
Additional paid-in capital 439,402 415,229
Accumulated other comprehensive (loss) / income (949) 1,604
Retained earnings 407,016 321,202
Total stockholders' equity 845,474 738,040
Total liabilities and stockholders' equity $909,194 $789,053
Gen-Probe Incorporated
Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Revenues:
Product sales $108,253 $97,402 $323,461 $278,451
Collaborative research revenue 11,343 3,118 18,453 11,239
Royalty and license revenue 1,581 1,213 21,640 14,375
Total revenues 121,177 101,733 363,554 304,065
Operating expenses:
Cost of product sales 30,6
'/>"/>
| SOURCE Gen-Probe Incorporated Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
2. Gen-Probe to Webcast Two Upcoming Investor Presentations
3. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
4. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
5. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
6. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
7. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
8. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
9. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
10. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
11. Nuvelo Reports Third Quarter 2008 Financial Results
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |